查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
乳房再造市場增長、趨勢、COVID-19 影響和預測 (2023-2028)
市場調查報告書
商品編碼
1190149

乳房再造市場增長、趨勢、COVID-19 影響和預測 (2023-2028)

Breast Reconstruction Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在預測期內，乳房重建市場預計將以 7.1% 的複合年增長率增長。

COVID-19 大流行對乳房植入物市場產生了短期影響，主要是在大流行的早期階段。 由於法規和封鎖，正在進行和預定的手術被推遲或取消，阻礙了乳房植入物市場的增長。 然而，在美國女性中 COVID-19 大流行期間，人們對外貌的興趣和意識有所增加，包括隆胸和隆胸。 例如，ASPS 在 2021 年 4 月的一份研究報告中發現，與大流行之前相比，接受調查的女性中有 11% 更傾向於整容或非手術程序。 因此，隨著從 COVID-19 大流行的影響中迅速恢復，市場有望增長。

推動所研究市場增長的主要因素是乳腺癌患病率的增加。 根據 GLOBOCAN 2020，乳腺癌已超過肺癌成為世界上診斷最多的癌症。 據世界衛生組織稱，2020 年全球約有 230 萬女性被診斷出患有乳腺癌。 在過去五年中，大約有 780 萬女性被診斷出患有乳腺癌。 亞洲女性的乳腺癌患病率很高，佔 2020 年所有女性癌症病例的 22.9%。 人們越來越意識到乳房重建方案的安全性，這讓接受乳房切除術和其他乳腺癌手術的女性在選□□擇重建過程時更加放心。

創新產品的興起正在推動市場的增長。 例如，2020 年 10 月，GC Esthetic 推出了一種新型圓形乳房植入物 Perle。 它採用反面技術開發，可減少炎症並更容易放置和切開。 這種先進的乳房植入物的引入有望促進市場增長。

因此，諸如乳腺癌發病率上升、全球人口意識提高以及創新產品推出等因素預計將推動研究市場的增長。 然而，乳房重建的高成本是製約市場增長的主要因素。

乳房再造市場趨勢

在預測期內，乳房植入物將佔據乳房再造市場的最大份額

乳房植入物在乳房重建手術中的使用在全球市場中佔有很大份額，預計在預測期內仍將是乳房重建市場的突出趨勢。

全球女性對隆胸和重建手術以增強美感的認識和偏好不斷提高，這也是有望推動所研究市場增長的因素之一。. 根據 2020 年國際美容整形外科學會 (ISAPS) 的統計數據，美國大約有 193,073 例乳房植入物，比任何其他整容手術都要多。

該領域的市場參與者不斷努力尋求更好、更高效的解決方案，通過新產品發布、合作和併購來延長可用產品的使用壽命，這也將補充乳房植入物領域的增長。 例如，2021 年 5 月，GC Esthetic Co., Ltd. 推出了名為 PERLE 的下一代乳房假體，這是一種光滑的乳房假體，採用了一種名為 BioQ 的獨特表面技術。

因此，考慮到上述所有因素，例如全球女性對隆胸和重建的認識和偏好不斷提高，以及新產品的推出，研究細分市場將在預測期內實現高速增長。去完成。

北美有望在預測期內主導市場

北美由於乳腺癌發病率高、隆胸手術增多以及醫療基礎設施成熟，預計將在預測期內主導所研究的市場。

例如，根據美國骨科醫師學會2020年的報告，隆胸將成為2020年美國排名前五的整容手術之一。 該地區乳腺癌患病率上升預計將推動該地區乳房植入物市場的增長。 根據 GLOBOCAN 2020 報告，2020 年美國、加拿大和墨西哥的乳腺癌新發病例數分別為 253,465 例、28,026 例和 29,929 例。 因此，預計在預測期內，北美將在乳房植入物市場佔據很大的市場份額。 有益的政府舉措和增加的研究夥伴關係預計將推動市場的增長。

預計不斷增加的產品批准將有助於該地區的市場增長。 例如，2022 年 3 月，Sientra Inc. 獲得加拿大衛生部的批准，可以在加拿大銷售其表面光滑、高強度粘性（HSC 和 HSC+）矽膠乳房植入物系列。 乳腺癌患病率的上升和該地區市場參與者的日益關注預計將推動北美乳房再造市場的增長。

乳房再造市場競爭分析

乳房再造市場競爭適中，由幾家大型企業組成。 目前主導市場的公司包括 Allergan、Sientra Inc.、Ideal Implant Incorporated、Johnson & Johnson、Establishment Labs SA、POLYTECH Health & Aesthetics GmbH、RTI Surgical Inc.、Groupe Sebbin SAS、Integra LifeSciences、GC Aesthetics。

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第一章介紹

  • 研究假設和市場定義
  • 調查範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

  • 市場概覽
  • 市場驅動力
    • 乳腺癌發病率增加
    • 技術先進的產品介紹
  • 市場製約因素
    • 乳房再造手術費用高昂
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（基於價值的市場規模：百萬美元）

  • 按產品分類
    • 乳房植入物
    • 組織擴張器
    • 針狀真皮基質
    • 其他產品
  • 最終用戶
    • 醫院
    • 門診
    • 其他最終用戶
  • 區域信息
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東和非洲
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲地區
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章競爭格局

  • 公司簡介
    • Allergan PLC
    • Sientra Inc.
    • Ideal Implant Incorporated
    • Johnson & Johnson
    • Establishment Labs SA
    • Polytech Health & Aesthetics GmbH
    • RTI Surgical Inc.
    • Groupe Sebbin SAS
    • Integra LifeSciences
    • GC Aesthetics
    • Sebbin
    • Silimed
    • Laboratories Arion

第7章 市場機會未來動向

簡介目錄
Product Code: 67873

The breast reconstruction market is projected to register a CAGR of 7.1% over the forecast period.

The COVID-19 pandemic had a short-term impact on the breast implant market, primarily during the initial phase of the pandemic. Due to restrictions and lockdown, the ongoing and scheduled surgical procedures were delayed or canceled, hindering the growth of the breast implant market. However, the interest and growing awareness regarding physical appearance increased during the COVID-19 pandemic among women in United States, including breast implants and augmentation. For instance, according to the April 2021 survey report by the ASPS, 11% of the surveyed women were more inclined toward cosmetic surgery or non-surgical procedures than before the pandemic. Therefore, the market is expected to recover soon from the impact of the COVID-19 pandemic and is expected to grow.

The major factor driving the growth of the market studied is the increasing incidence of breast cancer. According to GLOBOCAN 2020, breast cancer surpassed lung cancer and became the most diagnosed cancer worldwide. According to the WHO, in 2020, around 2.3 million women were diagnosed with breast cancer globally. About 7.8 million women have been diagnosed with breast cancer over the last five years. In Asian women, breast cancer prevalence was high, accounting for 22.9% of the total cancer cases in women in 2020. Increasing awareness about the safety of breast reconstruction options is reassuring women undergoing mastectomy and other breast cancer surgeries to choose the reconstruction process.

The increasing products of innovative products are boosting the market's growth. For instance, in October 2020, GC Aesthetics launched Perle, a novel round breast implant. It is developed with reverse surface technology allowing for reduced inflammation and easier placement and incision. Such introduction of advanced breast implants is expected to contribute to the growth of the market.

Thus, factors such as the increasing incidence of breast cancer, increasing awareness among the global population, and innovative product launches are expected to drive the growth of the market studied. However, the high cost of breast reconstruction procedures is the major factor restraining the growth of the market.

Breast Reconstruction Market Trends

Breast Implants Holds the Largest Share in the Breast Reconstruction Market Over the Forecast Period

The usage of breast implants in breast reconstruction surgeries accounted for a significant share of the global market, and this is expected to remain a prominent trend in the breast reconstruction market in the forecast period.

Increasing awareness and inclination among women across the world toward breast augmentation and reconstruction procedures for beauty enhancement is another factor expected to boost the growth of the market studied. According to the 2020 International Society for Aesthetic Plastic Surgeons (ISAPS) statistics, there were about 193,073 breast augmentation procedures in United States in 2020, which was more than any other performed aesthetic surgery.

The market players in the area are continuously working toward better and more efficient solutions and evolving the life of available products through new product launches, collaborations, and mergers and acquisitions, which will also complement the growth of the breast implant segment. For instance, in May 2021, GC Aesthetics Inc. launched a next-generation breast implant called PERLE, a smooth breast implant with a proprietary surface technology called BioQ.

Thus, considering all the above-mentioned factors, such as increasing awareness and inclination among women worldwide toward breast augmentation and reconstruction procedures and new product launches, the segment studied is expected to witness high growth over the forecast period.

North America is Expected to Dominate the Market Over the Forecast Period

North America is expected to dominate the market studied during the forecast period due to the high incidence of breast cancer, increasing breast augmentation procedures, and established healthcare infrastructure.

For instance, according to the 2020 report of the American Society of Plastic Surgeons, breast augmentation was one of the top five cosmetic surgical procedures in 2020 in United States. The increasing prevalence of breast cancer in this region is anticipated to boost the growth of the breast implant market in the region. According to the GLOBOCAN 2020 report, the new breast cancer cases in United States, Canada, and Mexico were 253,465, 28,026, and 29,929, respectively, in 2020. Therefore, North America is expected to hold a significant market share in the breast implant market during the forecast period. Beneficial government initiatives and increased research partnerships are expected to drive the market's growth.

The rising product approvals are expected to contribute to the growth of the market in this region. For instance, in March 2022, Sientra Inc. received approval from Health Canada to market the company's line of smooth surface, High-Strength Cohesive (HSC and HSC+) silicone gel breast implants in Canada. The rising prevalence of breast cancer and the increasing focus of market players in this region are expected to boost the growth of the breast reconstruction market in North America.

Breast Reconstruction Market Competitive Analysis

The breast reconstruction market is moderately competitive and consists of several major players. Some of the companies which are currently dominating the market are Allergan, Sientra Inc., Ideal Implant Incorporated, Johnson & Johnson, Establishment Labs SA, POLYTECH Health & Aesthetics GmbH, RTI Surgical Inc., Groupe Sebbin SAS, Integra LifeSciences, GC Aesthetics.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Incidence of Breast Cancer
    • 4.2.2 Introduction of Technologically Advanced Products
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Breast Reconstruction Procedures
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product
    • 5.1.1 Breast Implants
    • 5.1.2 Tissue Expanders
    • 5.1.3 Acellular Dermal Matrices
    • 5.1.4 Other Products
  • 5.2 By End User
    • 5.2.1 Hospitals
    • 5.2.2 Ambulatory Care Centers
    • 5.2.3 Other End Users
  • 5.3 By Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Allergan PLC
    • 6.1.2 Sientra Inc.
    • 6.1.3 Ideal Implant Incorporated
    • 6.1.4 Johnson & Johnson
    • 6.1.5 Establishment Labs SA
    • 6.1.6 Polytech Health & Aesthetics GmbH
    • 6.1.7 RTI Surgical Inc.
    • 6.1.8 Groupe Sebbin SAS
    • 6.1.9 Integra LifeSciences
    • 6.1.10 GC Aesthetics
    • 6.1.11 Sebbin
    • 6.1.12 Silimed
    • 6.1.13 Laboratories Arion

7 MARKET OPPORTUNITIES AND FUTURE TRENDS